Prenatal Opioid Exposure and Autoimmune‐Related Diseases in Children: A Cohort Study in South Korea and Japan

BACKGROUND: Prenatal opioid exposure has been associated with acute neonatal complications and longer-term immune-related outcomes, but its association with autoimmune diseases in children remains unclear. OBJECTIVES: To investigate the association between prenatal opioid exposure and the risk of autoimmune diseases in children. METHODS: We used the South Korean National Health Insurance Service (NHIS) birth cohort (discovery cohort; 2,930,720 children, 2,188,898 mothers) and the Japan Medical Data Center (JMDC) cohort (replication cohort; 176,528 children, 147,423 mothers). Children born between January 2010 and December 2017 were followed through December 2023. Prenatal opioid exposure was defined as at least two maternal opioid prescriptions during pregnancy. The primary outcome was any autoimmune-related disease, with 22 prespecified subcategories. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using propensity score overlap-weighted Cox models. Sibling-comparison analyses were conducted in both cohorts. RESULTS: In the South Korean cohort, 118,726 children (4.1%) were prenatally exposed to opioids. Exposure was associated with modestly increased risk of autoimmune-related diseases in overlap-weighted analyses in both South Korea (HR 1.05, 95% CI 1.02, 1.08) and Japan (HR 1.14, 95% CI 1.09, 1.20), with a pooled HR of 1.10 (95% CI 1.00, 1.20). Risks increased with greater numbers and longer durations of opioid prescriptions. Associations were observed for autoimmune thyroid disease (HR 1.06, 95% CI 1.01, 1.12), autoimmune adrenal and polyglandular diseases (HR 1.07, 95% CI 1.02, 1.12) and reactive arthritis (HR 1.10, 95% CI 1.00, 1.21). However, sibling-comparison analyses showed no association in South Korea or Japan. CONCLUSIONS: The absence of associations in sibling-comparison analyses suggests that shared familial, genetic or environmental factors may explain the observed population-level associations rather than a clinically meaningful independent effect of prenatal opioid exposure on autoimmune disease risk in offspring.

Authors

Institutions

Publication Details

Journal
Paediatric and Perinatal Epidemiology
Published
2026-11-13
DOI
https://doi.org/10.1111/ppe.70215
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prenatal Opioid Exposure and Autoimmune‐Related Diseases in Children: A Cohort Study in South Korea and Japan

Jaeyu Park, Dong Keon Yon, Jiseung Kang, Dongjin Yeo et al.
4 links
Paediatric and Perinatal Epidemiology
Prenatal Substance Exposure Effects
article

Prenatal Opioid Exposure and Autoimmune‐Related Diseases in Children: A Cohort Study in South Korea and Japan

Jaeyu Park, Dong Keon Yon, Jiseung Kang, Dongjin Yeo, Hyeon Seok Hwang, Sun Young Kim, Hyeon Jin Kim, Juyeong Kim, Hyunjee Kim
article en

Abstract

BACKGROUND: Prenatal opioid exposure has been associated with acute neonatal complications and longer-term immune-related outcomes, but its association with autoimmune diseases in children remains unclear. OBJECTIVES: To investigate the association between prenatal opioid exposure and the risk of autoimmune diseases in children. METHODS: We used the South Korean National Health Insurance Service (NHIS) birth cohort (discovery cohort; 2,930,720 children, 2,188,898 mothers) and the Japan Medical Data Center (JMDC) cohort (replication cohort; 176,528 children, 147,423 mothers). Children born between January 2010 and December 2017 were followed through December 2023. Prenatal opioid exposure was defined as at least two maternal opioid prescriptions during pregnancy. The primary outcome was any autoimmune-related disease, with 22 prespecified subcategories. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using propensity score overlap-weighted Cox models. Sibling-comparison analyses were conducted in both cohorts. RESULTS: In the South Korean cohort, 118,726 children (4.1%) were prenatally exposed to opioids. Exposure was associated with modestly increased risk of autoimmune-related diseases in overlap-weighted analyses in both South Korea (HR 1.05, 95% CI 1.02, 1.08) and Japan (HR 1.14, 95% CI 1.09, 1.20), with a pooled HR of 1.10 (95% CI 1.00, 1.20). Risks increased with greater numbers and longer durations of opioid prescriptions. Associations were observed for autoimmune thyroid disease (HR 1.06, 95% CI 1.01, 1.12), autoimmune adrenal and polyglandular diseases (HR 1.07, 95% CI 1.02, 1.12) and reactive arthritis (HR 1.10, 95% CI 1.00, 1.21). However, sibling-comparison analyses showed no association in South Korea or Japan. CONCLUSIONS: The absence of associations in sibling-comparison analyses suggests that shared familial, genetic or environmental factors may explain the observed population-level associations rather than a clinically meaningful independent effect of prenatal opioid exposure on autoimmune disease risk in offspring.

Paediatric and Perinatal Epidemiology
Korea University (KR), Kyung Hee University (KR), Kyung Hee University Medical Center (KR)
Kyung Hee University, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Good health and well-being
Prenatal Substance Exposure Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon